Effects of excitatory and inhibitory LIFUS of GPi in Parkinson’s patients without DBS
Official title: Effects of Excitatory and Inhibitory LIFUS of GPi in Parkinsonian Patients Without DBS
Run by University Health Network, Toronto · NCT07846007 · Data updated 2026-11-12
This study tests two deep-brain focused ultrasound patterns on people with Parkinson’s to see if they change task performance and tremor, compared with a sham stimulation.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 90 Years |
| Sex | All |
| Enrollment | 15 (estimated) |
| Sponsor | University Health Network, Toronto Academic / other |
| Locations | 1 site (Toronto, Ontario) |
| Status | Recruiting |
| Started | February 14, 2024 |
| Main results expected | December 2027 |
| Study ends | December 2028 |
| Registry record updated | September 29, 2026 |
| Trial ID | NCT07846007 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–90 with a confirmed Parkinson’s disease diagnosis, on a stable dopaminergic regimen for at least 4 weeks.
✕Probably not a fit
Individuals with a history of stroke or seizure, cognitive impairment (MoCA < 22), intracranial implants, implanted pacemakers/ICDs, prior movement disorder surgeries, or contraindicating metal implants may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will apply two deep brain stimulation-like ultrasound protocols to the GPi region in people with Parkinson’s disease, in random sessions with a sham comparison. Participants undergo baseline MRI, followed by three visits where different LIFUS patterns are delivered and tasks are performed, including a stop-signal task, UPDRS motor scoring, and finger tremor measurements. The study compares theta-burst and 10 Hz inhibitory stimulation against a sham condition to understand how these protocols may influence motor control and tremor. Outcomes include behavioral performance, motor scores, and tremor metrics to explore potential mechanisms and efficacy.
Why it matters
Potential benefit: If successful, participants could experience improvements in motor control and tremor and gain insight into non-invasive brain stimulation approaches for PD.
How similar studies have gone: Prior work on non-invasive brain stimulation has shown mixed results; this trial explores novel deep-brain LIFUS targets and protocols in PD, which is relatively new but builds on related neuromodulation approaches.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18-90 years of age * Confirmed diagnosis of Parkinson's disease * Stable dopaminergic medication dose for a minimum of 4 weeks Exclusion Criteria: * History of stroke or seizure * Comorbid dementia * Scored below 22 on the Montreal Cognitive Assessment (MoCA) * Has intracranial implant(s) or device(s) * Has an implanted cardiac pacemaker or implantable cardioverter-defibrillator (ICD) * Has a previous surgical intervention to treat the movement disorder such as lesioning or a Deep Brain Stimulation system in place. * Presence of metal implanted in body that is contraindicated in TMS/MRI/peripheral electrical stimulation * Pregnancy * Major depression/psychiatric disorder that in the opinion of the Investigator will affect patient's understanding of study procedures and willingness to abide by all procedures during the course of the study * Is on antipsychotics, anti-depressants, marijuana, or other recreational drugs that affect the nervous system * Major musculoskeletal or neuromuscular disease or disorder of the hands, wrists and limbs * Severe Dyskinesia * Major systemic illness or infection
Where it's running
-
Toronto Western Hospital
Toronto, Ontario, Canada Recruiting
Study contacts
- Principal investigator: Robert Chen, MBBS — University Health Network, Toronto
- Study coordinator: Julian Kwok
- Email: julian.kwok@uhn.ca
- Phone: 416-603-5800
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Parkinson’s Risk in Gaucher Disease Type 1
This study tests how Parkinson’s risk relates to GBA1-related Gaucher disease in adults over 40, by collecting detailed clinical data and samples for future research.
-
Can the Ronnie Gardiner Method improve thinking and daily function in people with Parkinson’s
In this 10-week program, adults with Parkinson’s disease will try the Ronnie Gardiner Method to see if it helps thinking, talking, movement, balance, and quality of life.
-
Capacitive-resistive radiofrequency therapy for people with Parkinson's disease
This study tests four TECAR therapy protocols on the legs to see which best reduces muscle stiffness and improves walking in people with Parkinson's disease.
-
TRB-001 safety and immune response in early Parkinson's disease
This early-phase study tests TRB-001 against placebo to see if it is safe and prompts an immune response in people with recently diagnosed Parkinson’s disease.
-
Bayesian optimization to tune DBS for better gait in Parkinson’s patients
This study tests whether using Bayesian optimization can quickly find DBS settings that lengthen step length in people with Parkinson's who already have DBS in place.
-
rTMS-primed self-controlled practice for people with Parkinson’s disease
This study tests whether priming motor training with rTMS and letting people with Parkinson’s control their practice improves motor learning and motivation.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.